Lower cortical porosity and higher tissue mineral density in Chinese American versus white women.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 23913668)

Published in J Bone Miner Res on March 01, 2014

Authors

Stephanie Boutroy1, Marcella D Walker, X Sherry Liu, Donald J McMahon, George Liu, X Edward Guo, John P Bilezikian

Author Affiliations

1: College of Physicians and Surgeons, Columbia University, New York, NY, USA.

Articles by these authors

The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med (2003) 7.25

One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis. N Engl J Med (2005) 4.03

Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation. N Engl J Med (2004) 3.44

Mechanisms of anabolic therapies for osteoporosis. N Engl J Med (2007) 3.33

A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell (2009) 3.28

High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J Clin Oncol (2009) 2.97

Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference. J Clin Densitom (2008) 2.87

American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract (2004) 2.69

International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Bone (2008) 2.53

Clinical review: Rare causes of hypercalcemia. J Clin Endocrinol Metab (2005) 2.38

Engineering anatomically shaped human bone grafts. Proc Natl Acad Sci U S A (2009) 2.37

Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis. Nat Med (2010) 2.32

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract (2011) 2.29

Executive summary of the 2013 International Society for Clinical Densitometry Position Development Conference on bone densitometry. J Clin Densitom (2013) 2.29

Clinical value of monitoring BMD in patients treated with bisphosphonates for osteoporosis. J Bone Miner Res (2009) 2.24

Quantification of the roles of trabecular microarchitecture and trabecular type in determining the elastic modulus of human trabecular bone. J Bone Miner Res (2006) 2.21

miR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2. J Cell Biol (2012) 2.15

The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab (2008) 2.12

Mechano-electrochemical properties of articular cartilage: their inhomogeneities and anisotropies. Annu Rev Biomed Eng (2002) 2.04

High-resolution peripheral quantitative computed tomography can assess microstructural and mechanical properties of human distal tibial bone. J Bone Miner Res (2010) 2.01

Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2012) 1.96

Spontaneous atherosclerosis in aged lipoprotein lipase-deficient mice with severe hypertriglyceridemia on a normal chow diet. Circ Res (2007) 1.94

Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol (2006) 1.91

Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol Metab (2006) 1.91

Complete volumetric decomposition of individual trabecular plates and rods and its morphological correlations with anisotropic elastic moduli in human trabecular bone. J Bone Miner Res (2008) 1.89

Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: a transiliac bone biopsy study. J Clin Endocrinol Metab (2013) 1.88

Differences in bone microarchitecture between postmenopausal Chinese-American and white women. J Bone Miner Res (2011) 1.86

Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res (2014) 1.86

Efficacy of serotonin inhibition in mouse models of bone loss. J Bone Miner Res (2011) 1.84

Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans. J Bone Miner Res (2008) 1.82

Doppler optical cardiogram gated 2D color flow imaging at 1000 fps and 4D in vivo visualization of embryonic heart at 45 fps on a swept source OCT system. Opt Express (2007) 1.79

Abnormal microarchitecture and reduced stiffness at the radius and tibia in postmenopausal women with fractures. J Bone Miner Res (2010) 1.78

Application of high-resolution skeletal imaging to measurements of volumetric BMD and skeletal microarchitecture in Chinese-American and white women: explanation of a paradox. J Bone Miner Res (2009) 1.76

Rapid cortical bone loss in patients with chronic kidney disease. J Bone Miner Res (2013) 1.74

Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. J Clin Endocrinol Metab (2004) 1.71

Anatomically shaped osteochondral constructs for articular cartilage repair. J Biomech (2003) 1.64

Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature. J Bone Miner Res (2012) 1.63

Bone microarchitecture and stiffness in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab (2009) 1.61

Vitamin D deficiency is associated with subclinical carotid atherosclerosis: the Northern Manhattan study. Stroke (2011) 1.57

Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate. J Clin Endocrinol Metab (2008) 1.53

The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin. Bone (2011) 1.51

Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab (2007) 1.51

Combination therapy with risedronate and teriparatide in male osteoporosis. Endocrine (2012) 1.50

Bone density, geometry, microstructure, and stiffness: Relationships between peripheral and central skeletal sites assessed by DXA, HR-pQCT, and cQCT in premenopausal women. J Bone Miner Res (2010) 1.50

Pancreas-kidney transplantation is associated with reduced fracture risk compared with kidney-alone transplantation in men with type 1 diabetes. Kidney Int (2013) 1.48

Seipin ablation in mice results in severe generalized lipodystrophy. Hum Mol Genet (2011) 1.46

Dynamic and structural properties of the skeleton in hypoparathyroidism. J Bone Miner Res (2008) 1.46

Individual trabeculae segmentation (ITS)-based morphological analysis of high-resolution peripheral quantitative computed tomography images detects abnormal trabecular plate and rod microarchitecture in premenopausal women with idiopathic osteoporosis. J Bone Miner Res (2010) 1.46

Carotid artery plaque thickness is associated with increased serum calcium levels: the Northern Manhattan study. Atherosclerosis (2006) 1.43

Osteoblast elastic modulus measured by atomic force microscopy is substrate dependent. Ann Biomed Eng (2005) 1.43

Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials. J Am Acad Child Adolesc Psychiatry (2003) 1.42

Accelerated fracture healing with teriparatide. Arq Bras Endocrinol Metabol (2013) 1.41

The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. J Clin Endocrinol Metab (2003) 1.41

Prevention of fractures after solid organ transplantation: a meta-analysis. J Clin Endocrinol Metab (2011) 1.41

Advanced tools for tissue engineering: scaffolds, bioreactors, and signaling. Tissue Eng (2006) 1.41

In vivo microMRI-based finite element and morphological analyses of tibial trabecular bone in eugonadal and hypogonadal men before and after testosterone treatment. J Bone Miner Res (2008) 1.40

Individual trabecula segmentation (ITS)-based morphological analyses and microfinite element analysis of HR-pQCT images discriminate postmenopausal fragility fractures independent of DXA measurements. J Bone Miner Res (2012) 1.40

"Incipient" primary hyperparathyroidism: a "forme fruste" of an old disease. J Clin Endocrinol Metab (2003) 1.39

Growth and skeletal maturation after pediatric cardiac transplantation. Pediatr Transplant (2004) 1.38

Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and β-cell Function in type 2 diabetic patients. Diabetes (2013) 1.37

Zoledronic acid prevents bone loss in premenopausal women undergoing adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol (2008) 1.36

Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab (2014) 1.35

Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vivo. Proc Natl Acad Sci U S A (2008) 1.34

Better skeletal microstructure confers greater mechanical advantages in Chinese-American women versus white women. J Bone Miner Res (2011) 1.34

Perspectives on glucocorticoid-induced osteoporosis. Bone (2004) 1.34

An application of nanoindentation technique to measure bone tissue Lamellae properties. J Biomech Eng (2005) 1.32

PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism. J Bone Miner Res (2011) 1.30

Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures. J Clin Endocrinol Metab (2003) 1.30

Optimizing the medium perfusion rate in bone tissue engineering bioreactors. Biotechnol Bioeng (2010) 1.28

Bone mass and microarchitecture in CKD patients with fracture. J Am Soc Nephrol (2010) 1.26